Talking Heads – The weighty impact of anti-obesity drugs, also for investors

Talking Heads – The weighty impact of anti-ob...

Up next

Talking Heads - Cheaper, smarter and ever broader uses: AI offers a long growth runway

Artificial intelligence (AI) models continue to get smarter and cheaper, spurring adoption and expanding the total addressable market. Pamela Hegarty and Derek Glynn, Co-portfolio Managers of BNPP AM’s disruptive technology strategy provide Daniel Morris, Chief Market Strategist, ...  Show more

Talking Heads - ETF investing in European defence

The geopolitical pressures forcing Europe to develop an autonomous defence capability are unrelenting. Listen to George Ferguson, Senior Analyst for Aerospace, Defence and Airlines at Bloomberg Intelligence, update Andrew Craig, Co-head of the Investment Insights Centre about pro ...  Show more

Recommended Episodes

Influencer Marketing Strategy: How to Scale a Business
Social Media Marketing Podcast

Wondering if influencers can help you grow your business? Wondering how to work with influencers? To explore influencer marketing, in this episode I interview Adi Arezzini. Adi is an influencer marketing expert, and the CEO and co-founder of Teami Blends—a lifestyle brand that c ...  Show more

The Big Business Behind Weight Loss Drugs
Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

How luxury furniture brand and Magento user OKA went sustainable with Mirry Christie
eCommerce MasterPlan

Mirry Christie is a Brand and Marketing Director turned Sustainability Consultant who’s been helping furniture and lifestyle brand OKA to not only become a more sustainable business, but also to inspire their customers to create sustainable homes.

OKA was founded in 199 ...

  Show more

Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker
The Prof G Pod with Scott Galloway

This week on Prof G Markets, Scott gives the inside scoop on his early investment in NJOY, which will reap 30x in returns after Altria's acquisition of the vape company goes through. He also shares his thoughts on whether or not the JetBlue/Spirit Merger should be blocked, and ta ...  Show more